Diabetes device recalls surge as CMS eyes payment changes
Supply Chain Pulse — 2026-04-21
Diabetes device recalls jumped sharply in 2025, exposing critical gaps in how clinicians and patients get notified when life-sustaining equipment fails. The recall surge comes as CMS proposes a 2.4% Medicare payment bump for fiscal 2027 and revives bundled payment models for joint replacements—moves that could reshape how hospitals budget for both device costs and outcome-based care. Between recall management chaos and evolving payment structures, supply chain teams are facing a perfect storm of operational complexity right as medtech companies mark one year of tariff navigation strategies.
Quick Hits
- Three health systems receive $125M from Paychex founder for primary care expansion (Modern Healthcare)
- Insurer coalition cuts prior authorizations by 11%, Medicare Advantage down 15% (Modern Healthcare)
Diabetes device recall surge reveals worrying information gap
Diabetes device recalls jumped in 2025, amplifying concerns about how and when clinicians and patients are notified of failures. For supply chain managers, this highlights the urgent need for robust recall tracking systems and alternative sourcing strategies for critical devices like CGMs and insulin pumps. The communication breakdowns could expose hospitals to liability risks and patient safety issues.
CMS proposes 2.4% hospital pay bump, revives joint replacement model
Medicare payments for inpatient hospital services would rise 2.4% in fiscal 2027 under CMS's proposed rule, while also reviving bundled payment models for hip, knee, and ankle replacements. The payment increase provides some relief for hospitals managing inflation pressures on supplies and labor. However, the return of bundled payments means supply chain teams need to optimize implant costs and post-acute care coordination to hit profitability targets.
Medtech companies adapt strategies one year into tariff challenges
After a year of navigating Trump administration trade policies, medtech companies are implementing proactive cost management strategies as tariffs continue to evolve. Supply chain leaders should expect ongoing price volatility for imported devices and components, with companies likely passing some costs downstream. The industry's resilience suggests established players are finding ways to absorb impacts, but smaller suppliers may struggle more.
Source: Supply Chain Dive - Healthcare
Medtronic completes $585M CathWorks acquisition
Medtronic closed its $585 million acquisition of CathWorks, a company specializing in coronary artery disease diagnosis and treatment technology. The deal signals continued consolidation in the cardiac device space, potentially affecting pricing and product availability for hospitals. Supply chain managers should monitor how this integration impacts CathWorks' existing product lines and distribution channels.
Source: Medical Device Network
Health systems push performance-based contracts for digital health
Health systems are increasingly structuring digital health vendor contracts to tie payments to measurable outcomes and ROI rather than traditional fee structures. This shift requires supply chain teams to develop new evaluation metrics and contract management processes for software and digital tools. The trend reflects growing scrutiny of health tech investments that haven't delivered promised returns.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe